SARCOMAS
Clinical trials for SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SARCOMAS trials appear
Sign up with your email to follow new studies for SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called ZL-6201. The main goal is to find a safe dose and see how the body processes the drug in adults with advanced sarcoma or certain other solid tumors that have stopped responding to standard treatments. Researchers…
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New hope for tough cancers: early trial tests combo therapy
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of combining two drugs, cabozantinib and high-dose ifosfamide, for children and adults whose bone or soft tissue sarcomas have returned or not responded to standard chemotherapy. The main goal is to find the s…
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Two-Drug spinal shot tested to ease agony of cancer amputation
Symptom relief Recruiting nowThis study is testing whether adding a drug called dexmedetomidine to a standard spinal anesthesia mix provides better and longer-lasting pain relief after leg amputation surgery for bone or soft tissue cancer (sarcoma). Researchers will compare the combination against the standa…
Matched conditions: SARCOMAS
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC